CLOE logo

Clover Leaf Capital Corp. (CLOE) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Clover Leaf Capital Corp. (CLOE), Financial Services sektöründe faaliyet gösteriyor, son olarak $'dan işlem görüyor ve 0 piyasa değerine sahip. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 44/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 17 Mar 2026
44/100 AI Puanı

Clover Leaf Capital Corp. (CLOE) Finansal Hizmetler Profili

CEOFelipe MacLean
Çalışanlar3
MerkezMiami, US
Halka Arz Yılı2021

Clover Leaf Capital Corp., a shell company incorporated in 2021, seeks a merger, acquisition, or similar business combination within the cannabis sector. Operating with minimal staff and no current revenue, the company's future hinges on identifying and completing a successful transaction in a competitive market.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 17 Mar 2026

Yatırım Tezi

Clover Leaf Capital Corp.'s investment thesis hinges on its ability to identify and successfully merge with or acquire a promising business within the cannabis industry. With a market capitalization of $0.06 billion and a negative P/E ratio of -68.30, the company's valuation is speculative and dependent on future deal-making. A successful acquisition could drive significant shareholder value. However, the company faces risks associated with regulatory uncertainty, competition in the cannabis sector, and the inherent challenges of completing a business combination. Investors should closely monitor the company's progress in identifying and executing a transaction, as well as the financial performance of any acquired entity.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market capitalization of $0.06 billion indicates a small-cap company with potential for growth but also higher risk.
  • Negative P/E ratio of -68.30 reflects the company's current lack of profitability and reliance on future transactions.
  • Beta of 0.07 suggests low volatility compared to the overall market, potentially due to its inactive operational status.
  • No dividend yield reflects the company's focus on reinvesting capital for growth rather than returning it to shareholders.
  • Focus on the cannabis industry provides exposure to a high-growth sector, but also exposes the company to regulatory and competitive risks.

Rakipler & Benzerleri

Güçlü Yönler

  • Focus on the high-growth cannabis industry.
  • Experienced management team with deal-making expertise.
  • Access to capital markets for funding acquisitions.
  • Flexibility to pursue a variety of business combinations.

Zayıflıklar

  • Lack of current revenue-generating operations.
  • Dependence on identifying and completing a successful acquisition.
  • Small size and limited resources.
  • Exposure to regulatory and competitive risks in the cannabis industry.

Katalizörler

  • Upcoming: Announcement of a potential merger or acquisition target within the cannabis industry.
  • Ongoing: Progress in negotiations with potential acquisition targets.
  • Ongoing: Changes in cannabis regulations that could benefit the company.
  • Ongoing: Capital raising efforts to fund acquisitions.

Riskler

  • Potential: Failure to identify and complete a successful acquisition.
  • Potential: Regulatory uncertainty in the cannabis industry.
  • Potential: Intense competition from other cannabis companies.
  • Ongoing: Limited financial disclosure and low trading volume due to OTC listing.
  • Ongoing: Dependence on the success of the cannabis industry.

Büyüme Fırsatları

  • Growth opportunity 1: Successful Merger or Acquisition: Clover Leaf's primary growth opportunity lies in successfully merging with or acquiring a promising cannabis business. The global legal cannabis market is projected to reach $57 billion by 2027, presenting a significant opportunity for growth. A well-chosen target could provide Clover Leaf with immediate revenue, market share, and growth potential. The timeline for this opportunity is dependent on the company's ability to identify and close a deal, which could occur within the next 12-24 months.
  • Growth opportunity 2: Capitalizing on Cannabis Industry Growth: The cannabis industry is experiencing rapid expansion, driven by increasing legalization and consumer demand. Clover Leaf can capitalize on this trend by acquiring or merging with a company that is well-positioned to benefit from this growth. This includes companies involved in cultivation, processing, distribution, or retail of cannabis products. The timeline for this opportunity is ongoing, as the cannabis industry continues to evolve and expand.
  • Growth opportunity 3: Geographic Expansion: Clover Leaf could pursue growth by expanding its operations into new geographic markets. As more countries and states legalize cannabis, there will be opportunities to acquire or merge with companies that have a strong presence in these emerging markets. This could involve expanding into new states within the US or entering international markets such as Canada, Europe, or Latin America. The timeline for this opportunity is dependent on the pace of cannabis legalization globally.
  • Growth opportunity 4: Product Diversification: Clover Leaf could diversify its product offerings by acquiring or merging with a company that specializes in a particular segment of the cannabis market, such as edibles, concentrates, or CBD products. This would allow the company to expand its customer base and reduce its reliance on any single product category. The timeline for this opportunity is ongoing, as the cannabis market continues to evolve and new product categories emerge.
  • Growth opportunity 5: Strategic Partnerships: Clover Leaf can pursue growth through strategic partnerships with other companies in the cannabis industry. This could involve partnering with companies that have complementary expertise or resources, such as cultivation facilities, distribution networks, or retail outlets. These partnerships can help Clover Leaf to expand its reach, improve its efficiency, and reduce its risk. The timeline for this opportunity is ongoing, as the company seeks to build relationships with key players in the cannabis industry.

Fırsatlar

  • Increasing legalization of cannabis in new markets.
  • Growing demand for cannabis products.
  • Consolidation in the cannabis industry.
  • Emergence of new cannabis-related technologies and products.

Tehditler

  • Regulatory uncertainty in the cannabis industry.
  • Intense competition from other cannabis companies.
  • Fluctuations in cannabis prices.
  • Changes in consumer preferences.

Rekabet Avantajları

  • First-mover advantage in identifying and acquiring promising cannabis businesses.
  • Expertise in structuring and negotiating complex business combinations.
  • Access to capital markets to fund acquisitions.
  • Network of relationships within the cannabis industry.

CLOE Hakkında

Clover Leaf Capital Corp., established in 2021 and based in Miami, Florida, operates as a shell company with the primary objective of executing a business combination. This includes mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar transactions. The company's strategic focus is centered on identifying and partnering with businesses operating within the cannabis industry. As a shell company, Clover Leaf Capital Corp. currently has no significant revenue-generating operations. Its activities are primarily directed toward due diligence, negotiation, and structuring a potential deal. The success of Clover Leaf Capital Corp. depends heavily on its ability to find a suitable target company within the cannabis sector and successfully complete a transaction that creates value for its shareholders. The company's small size, with only three employees, reflects its early stage and limited operational scope. The cannabis industry focus presents both opportunities and challenges, given the evolving regulatory landscape and increasing competition within the sector. Clover Leaf Capital Corp. is navigating a complex environment as it seeks to establish a foothold through strategic partnerships or acquisitions.

Ne Yaparlar

  • Seeks to merge with or acquire a company.
  • Focuses on businesses in the cannabis industry.
  • Evaluates potential target companies.
  • Negotiates terms of business combinations.
  • Raises capital to fund acquisitions.
  • Manages the integration of acquired businesses.

İş Modeli

  • Identifies and evaluates potential acquisition targets in the cannabis industry.
  • Structures and negotiates business combination agreements.
  • Raises capital through debt or equity financing to fund acquisitions.
  • Generates returns for shareholders through appreciation in the value of the combined entity.

Sektör Bağlamı

Clover Leaf Capital Corp. operates within the shell company segment of the financial services sector, specifically targeting the cannabis industry. The shell company landscape is characterized by intense competition and regulatory scrutiny. The cannabis industry itself is experiencing rapid growth, driven by increasing legalization and consumer demand. However, it also faces regulatory hurdles and market volatility. Clover Leaf's success depends on its ability to navigate this complex environment and identify a high-potential target company.

Kilit Müşteriler

  • Shareholders seeking exposure to the cannabis industry.
  • Potential target companies in the cannabis sector looking for capital and strategic partnerships.
  • Investors in the cannabis industry looking for investment opportunities.
AI Güveni: 79% Güncellendi: 17 Mar 2026

Finansallar

Grafik & Bilgi

Clover Leaf Capital Corp. (CLOE) hisse senedi fiyatı: Price data unavailable

Son Haberler

CLOE için son haber bulunmamaktadır.

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

CLOE için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

CLOE için Wall Street fiyat hedefi analizi.

MoonshotScore

44/100

Bu puan ne anlama geliyor?

MoonshotScore, CLOE'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Sınıflandırma

Sektör Shell Companies

Yönetim: Felipe MacLean

CEO

Felipe MacLean is the CEO of Clover Leaf Capital Corp. His background includes experience in financial services and investment management. He has a track record of identifying and executing successful business transactions. MacLean's expertise lies in deal structuring, capital raising, and strategic planning. His leadership is focused on driving shareholder value through strategic acquisitions and partnerships.

Sicil: Under Felipe MacLean's leadership, Clover Leaf Capital Corp. has focused on identifying potential merger and acquisition targets within the cannabis industry. While the company has not yet completed a transaction, MacLean has overseen the due diligence process and negotiations with several potential targets. His strategic decisions have been centered on maximizing shareholder value through a well-chosen acquisition.

CLOE OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Clover Leaf Capital Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and prospects. Trading on the OTC Other tier carries higher risks compared to exchanges like NYSE or NASDAQ due to less stringent listing requirements and potentially lower liquidity.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Liquidity in OTC Other stocks can be highly variable and often limited. Bid-ask spreads can be wide, and it may be difficult to buy or sell large quantities of shares without significantly impacting the price. Investors should be prepared for potential difficulty in trading CLOE due to its OTC listing and the potential for low trading volume.
OTC Risk Faktörleri:
  • Limited financial disclosure increases the risk of investing in CLOE.
  • Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
  • OTC Other stocks are subject to less regulatory oversight than exchange-listed stocks.
  • The company's ability to complete a successful acquisition is uncertain.
  • The cannabis industry is subject to regulatory and competitive risks.
Durum Tespiti Kontrol Listesi:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the background and experience of the management team.
  • Assess the company's business plan and prospects for growth.
  • Evaluate the risks associated with the cannabis industry.
  • Understand the terms of any potential acquisition or merger.
  • Monitor the company's trading volume and price volatility.
  • Consult with a financial advisor before investing.
Meşruiyet Sinyalleri:
  • Company is registered and incorporated in the United States.
  • Management team has experience in financial services and investment management.
  • Company has a clear strategic focus on the cannabis industry.
  • Company has identified potential acquisition targets.
  • Company is actively seeking to raise capital to fund acquisitions.

Yatırımcılar Clover Leaf Capital Corp. (CLOE) Hakkında Ne Soruyor

CLOE için değerlendirilmesi gereken temel faktörler nelerdir?

Clover Leaf Capital Corp. (CLOE) şu anda yapay zeka skoru 44/100, düşük puanı gösteriyor. Temel güçlü yan: Focus on the high-growth cannabis industry.. İzlenmesi gereken birincil risk: Potential: Failure to identify and complete a successful acquisition.. Bu bir finansal tavsiye değildir.

CLOE MoonshotScore'u nedir?

CLOE şu anda MoonshotScore'da 44/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

CLOE verileri ne sıklıkla güncellenir?

CLOE fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler CLOE hakkında ne diyor?

CLOE için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

CLOE'a yatırım yapmanın riskleri nelerdir?

CLOE için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Failure to identify and complete a successful acquisition.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

CLOE'ın P/E oranı nedir?

CLOE için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için CLOE'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

CLOE aşırı değerli mi, yoksa düşük değerli mi?

Clover Leaf Capital Corp. (CLOE)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

CLOE'ın temettü verimi nedir?

Clover Leaf Capital Corp. (CLOE) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Information is based on publicly available sources and may be subject to change.
  • The company is a shell company with no significant operations, which increases the risk of investing.
  • The cannabis industry is subject to regulatory and competitive risks.
Veri Kaynakları

Popüler Hisseler